tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GSK Stock Latest News

GSK’s New Phase 3 Study: A Potential Game-Changer in Lung Cancer Treatment
Company AnnouncementsGSK’s New Phase 3 Study: A Potential Game-Changer in Lung Cancer Treatment
17h ago
GSK
GSK’s Bepirovirsen Study: A Potential Game-Changer for Hepatitis B Treatment?
PremiumCompany Announcements
GSK’s Bepirovirsen Study: A Potential Game-Changer for Hepatitis B Treatment?
17h ago
GSK
GSK’s Mepolizumab Study: A Potential Game-Changer in Severe Asthma Treatment
PremiumCompany Announcements
GSK’s Mepolizumab Study: A Potential Game-Changer in Severe Asthma Treatment
18h ago
GSK
GSK’s Q2 2025 Earnings Call: Strong Growth Amid Challenges
PremiumCompany Announcements
GSK’s Q2 2025 Earnings Call: Strong Growth Amid Challenges
1d ago
GSK
Is MRNA Stock (MRNA) a Buy Ahead of Q2 Earnings?
PremiumMarket News
Is MRNA Stock (MRNA) a Buy Ahead of Q2 Earnings?
1d ago
GSK
MRK
Trump posts letters calling on drug company CEOs to lower prices
PremiumThe FlyTrump posts letters calling on drug company CEOs to lower prices
2d ago
AZN
BMY
Press Secretary says Trump sent letters today to pharmaceutical companies
Premium
The Fly
Press Secretary says Trump sent letters today to pharmaceutical companies
2d ago
AZN
BMY
GSK’s Belimumab Study: A Potential Game-Changer for Lupus Treatment?
Premium
Company Announcements
GSK’s Belimumab Study: A Potential Game-Changer for Lupus Treatment?
2d ago
GSK
GlaxoSmithKline Reports Strong Q2 2025 Performance
PremiumCompany Announcements
GlaxoSmithKline Reports Strong Q2 2025 Performance
2d ago
GSK
Cautious Outlook on GlaxoSmithKline: Sell Rating Amid Earnings Concerns and Market Uncertainties
PremiumRatings
Cautious Outlook on GlaxoSmithKline: Sell Rating Amid Earnings Concerns and Market Uncertainties
3d ago
GSK
GSK reports Q2 core EPS 46.5p, up 15% at CER
PremiumThe Fly
GSK reports Q2 core EPS 46.5p, up 15% at CER
3d ago
GSK
GSK revises FY25 guidance at CER, with core EPS towards top end 6%-8%
PremiumThe Fly
GSK revises FY25 guidance at CER, with core EPS towards top end 6%-8%
3d ago
GSK
GSK’s Belimumab Study: A Potential Game-Changer for Early SLE Treatment
PremiumCompany AnnouncementsGSK’s Belimumab Study: A Potential Game-Changer for Early SLE Treatment
4d ago
GSK
Trump administration mulls charging patent holders 1%-5% fee, WSJ reports
Premium
The Fly
Trump administration mulls charging patent holders 1%-5% fee, WSJ reports
5d ago
AZN
BMY
GSK’s Long-Term Study on Atopic Dermatitis Drug: A Potential Game Changer?
Premium
Company Announcements
GSK’s Long-Term Study on Atopic Dermatitis Drug: A Potential Game Changer?
5d ago
GSK
GSK’s Promising Phase 3 Study on Belimumab for ILD: Key Insights for Investors
PremiumCompany Announcements
GSK’s Promising Phase 3 Study on Belimumab for ILD: Key Insights for Investors
5d ago
GSK
GSK’s Innovative Hepatitis B Treatment Study: A Potential Game-Changer?
PremiumCompany Announcements
GSK’s Innovative Hepatitis B Treatment Study: A Potential Game-Changer?
5d ago
GSK
GSK, Hengrui Pharma enter agreements to develop up to 12 medicines
PremiumThe Fly
GSK, Hengrui Pharma enter agreements to develop up to 12 medicines
5d ago
GSK
GSK Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
GSK Upcoming Earnings Report: What to Expect?
5d ago
GSK
GSK’s Phase 2 Trial on Dostarlimab for Endometrial Cancer: A Market Game Changer?
PremiumCompany AnnouncementsGSK’s Phase 2 Trial on Dostarlimab for Endometrial Cancer: A Market Game Changer?
8d ago
GSK
GSK’s HSV Immunotherapy Study: A Potential Game Changer in Herpes Treatment
Premium
Company Announcements
GSK’s HSV Immunotherapy Study: A Potential Game Changer in Herpes Treatment
8d ago
GSK
GSK’s Promising Update: Belantamab Mafodotin and Nirogacestat in RRMM Study
Premium
Company Announcements
GSK’s Promising Update: Belantamab Mafodotin and Nirogacestat in RRMM Study
8d ago
GSK

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >